{"gene":"MORC4","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2020,"finding":"MORC4 has intrinsic ATPase activity that is dependent on DNA-binding functions of both its ATPase domain and CW domain; the crystal structure of the ATPase-CW cassette shows that the DNA-binding site and the histone/ATPase binding site of CW are on opposite sides of the domain; MORC4 and CW domains cooperate to bind the nucleosome core particle (NCP), enhancing DNA wrapping around the histone core and impeding binding of DNA-associated proteins such as transcription factors to the NCP.","method":"Enzymatic ATPase assays, binding assays, crystal structure determination, mutagenesis studies, nucleosome core particle binding assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus enzymatic assays plus mutagenesis in a single rigorous study","pmids":["33122719"],"is_preprint":false},{"year":2020,"finding":"In cells, MORC4 mediates formation of nuclear bodies in the nucleus and has a role in progression of S-phase of the cell cycle; both functions require the CW domain and catalytic ATPase activity of MORC4.","method":"Cell-based assays with CW domain and catalytic mutants, nuclear body imaging, cell cycle analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function with domain-specific mutants and defined cellular phenotypes in a rigorous study","pmids":["33122719"],"is_preprint":false},{"year":2020,"finding":"MORC4 physically interacts with STAT3 (confirmed by Co-IP), and MORC4 promotes STAT3-mediated transcriptional activation of the MID2 promoter (confirmed by ChIP-qPCR and dual-luciferase assay), leading to MID2 upregulation and chemoresistance in luminal A/B breast cancer cells.","method":"Co-immunoprecipitation, ChIP-qPCR, dual-luciferase reporter assay, siRNA knockdown/overexpression","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP plus ChIP and reporter assay, single lab","pmids":["32764967"],"is_preprint":false},{"year":2023,"finding":"MORC4 physically interacts with PCGF1 (a transcriptional repressor of CDKN1A/p21) as shown by co-immunoprecipitation; MORC4 augments PCGF1-mediated repression of CDKN1A transcription, thereby promoting colorectal cancer cell proliferation and metastasis.","method":"Co-immunoprecipitation, luciferase reporter assay, siRNA knockdown, overexpression","journal":"Cancer gene therapy","confidence":"Medium","confidence_rationale":"Tier 3 — single Co-IP with reporter assay and functional rescue, single lab","pmids":["36932196"],"is_preprint":false},{"year":2023,"finding":"MORC4 protein is degraded through the ubiquitin-proteasome system and acts as a substrate of the E3 ubiquitin ligase HECW2.","method":"Co-immunoprecipitation, proteasome inhibitor assays, ubiquitination assays","journal":"Cancer gene therapy","confidence":"Low","confidence_rationale":"Tier 3 — single lab, single method, limited mechanistic detail in abstract","pmids":["36932196"],"is_preprint":false},{"year":2018,"finding":"miR-193b-3p directly targets the 3' UTR of MORC4 mRNA and negatively regulates MORC4 protein levels in breast cancer cells; MORC4 silencing promotes apoptosis and suppresses breast cancer cell growth.","method":"Dual-luciferase reporter assay, Western blot, siRNA knockdown, miRNA overexpression","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 3 — luciferase reporter plus functional rescue, replicated in cell lines and tissues","pmids":["30320920"],"is_preprint":false},{"year":2019,"finding":"miR-338-3p directly targets MORC4 (confirmed by luciferase reporter assay and RNA immunoprecipitation); baicalin upregulates miR-338-3p, leading to decreased MORC4 expression and suppressed breast cancer cell viability, migration, and invasion.","method":"Luciferase reporter assay, RNA immunoprecipitation, Western blot, MTT assay, transwell migration/invasion, flow cytometry","journal":"OncoTargets and therapy","confidence":"Medium","confidence_rationale":"Tier 3 — luciferase and RIP confirm direct miR-MORC4 interaction, functional rescue shown","pmids":["31908485"],"is_preprint":false},{"year":2024,"finding":"lncRNA RP3-340B19.3 acts as a competing endogenous RNA (ceRNA) by sponging miR-4510, thereby upregulating MORC4 expression and activating NF-κB and Wnt-β-catenin signaling pathways to promote breast cancer proliferation and metastasis.","method":"Dual luciferase reporter assay, Western blotting, bioinformatics, transwell and clone formation assays","journal":"Cancer cell international","confidence":"Low","confidence_rationale":"Tier 3 — single lab, indirect ceRNA mechanism, limited mechanistic validation of MORC4's downstream role","pmids":["39256868"],"is_preprint":false},{"year":2007,"finding":"MORC4 protein contains a HATPase-c domain, CW zinc finger motif, nuclear localisation signals, a nuclear matrix-binding domain, and a coiled-coil region, establishing its domain architecture and nuclear localization.","method":"Sequence analysis, antibody detection, mRNA expression profiling in cell lines","journal":"British journal of haematology","confidence":"Low","confidence_rationale":"Tier 4 — domain identification by sequence analysis; no direct functional assay of domains","pmids":["17608765"],"is_preprint":false},{"year":2025,"finding":"MORC4 knockdown in hepatocytes elevates total cholesterol and triglyceride levels and increases lipid accumulation, while MORC4 overexpression reverses these effects; MORC4 knockdown increases expression of cholesterol synthesis gene HMGCR and alters expression of fatty acid/cholesterol uptake genes (PCSK9, PLTP, CD36) and triglyceride hydrolysis genes (APOC2, APOA4, LIPG, LIPA), indicating a role for MORC4 in hepatic lipid metabolism.","method":"siRNA knockdown, overexpression, TC/TG assays, lipid accumulation assays, gene expression analysis in hepatocytes; in vivo Morc4 knockout mouse data from IMPC database","journal":"Frontiers in cardiovascular medicine","confidence":"Low","confidence_rationale":"Tier 3 — single lab, cellular phenotype without direct pathway placement or molecular mechanism","pmids":["40606021"],"is_preprint":false}],"current_model":"MORC4 is a nuclear ATPase whose catalytic activity is activated by cooperative DNA binding through both its ATPase and CW domains; it binds nucleosome core particles to enhance DNA wrapping and occlude transcription factor access, interacts with STAT3 to drive MID2 transcription and chemoresistance, interacts with PCGF1 to repress CDKN1A, is subject to HECW2-mediated ubiquitin-proteasome degradation, is negatively regulated post-transcriptionally by miR-193b-3p and miR-338-3p, mediates nuclear body formation and S-phase progression in a CW- and ATPase-dependent manner, and regulates hepatic lipid metabolism."},"narrative":{"teleology":[{"year":2007,"claim":"Initial characterization established the domain architecture of MORC4 — including its ATPase, CW zinc-finger, nuclear localization signals, and coiled-coil regions — providing the first framework for predicting its nuclear function.","evidence":"Sequence analysis and antibody detection in cell lines","pmids":["17608765"],"confidence":"Low","gaps":["No functional assays of any domain were performed","Nuclear localization inferred from sequence motifs, not imaging","Enzymatic activity of the predicted ATPase domain untested"]},{"year":2018,"claim":"The identification of miR-193b-3p as a direct negative regulator of MORC4 mRNA established that MORC4 expression is subject to microRNA-mediated post-transcriptional control and linked MORC4 levels to breast cancer cell survival.","evidence":"Dual-luciferase reporter assay confirming 3′ UTR targeting, Western blot, and functional knockdown in breast cancer cell lines","pmids":["30320920"],"confidence":"Medium","gaps":["Downstream effectors of MORC4 in the pro-survival phenotype were not identified","In vivo validation of miR-193b-3p–MORC4 axis absent"]},{"year":2019,"claim":"A second microRNA, miR-338-3p, was shown to directly target MORC4, reinforcing the post-transcriptional regulatory layer and connecting MORC4 downregulation to suppressed breast cancer migration and invasion.","evidence":"Luciferase reporter assay and RNA immunoprecipitation confirming direct binding, functional rescue in breast cancer cells","pmids":["31908485"],"confidence":"Medium","gaps":["Relative contributions of miR-193b-3p versus miR-338-3p to endogenous MORC4 regulation unclear","The pharmacological agent (baicalin) used to upregulate the miRNA adds confounding variables"]},{"year":2020,"claim":"Structural and biochemical work resolved how MORC4 functions as a DNA-stimulated ATPase: the crystal structure of the ATPase-CW cassette revealed cooperative DNA binding by both domains, and nucleosome core particle assays showed MORC4 enhances histone–DNA wrapping while occluding transcription factor binding, establishing its chromatin-remodeling mechanism.","evidence":"Crystal structure determination, enzymatic ATPase assays, mutagenesis, and nucleosome core particle binding assays","pmids":["33122719"],"confidence":"High","gaps":["Genomic targets of MORC4's nucleosome-remodeling activity in vivo are unknown","Whether MORC4 acts catalytically (turnover on multiple nucleosomes) or stoichiometrically is unresolved"]},{"year":2020,"claim":"Cell-based studies demonstrated that MORC4 drives nuclear body formation and S-phase progression through its CW domain and ATPase catalytic activity, linking the in vitro biochemistry to defined cellular phenotypes.","evidence":"CW and catalytic-dead mutant analysis, nuclear body imaging, cell cycle analysis","pmids":["33122719"],"confidence":"High","gaps":["Composition of MORC4-containing nuclear bodies is uncharacterized","Mechanism connecting nucleosome remodeling to S-phase progression is not delineated"]},{"year":2020,"claim":"MORC4 was shown to physically interact with STAT3 and co-occupy the MID2 promoter, establishing a transcriptional co-activator function that promotes chemoresistance in breast cancer cells.","evidence":"Co-immunoprecipitation, ChIP-qPCR, dual-luciferase reporter assay, and siRNA knockdown in luminal A/B breast cancer cells","pmids":["32764967"],"confidence":"Medium","gaps":["Whether MORC4's ATPase or nucleosome-remodeling activity is required for STAT3 co-activation is untested","Generality of MORC4–STAT3 cooperation beyond the MID2 locus unknown"]},{"year":2023,"claim":"The discovery that MORC4 interacts with PCGF1 to repress CDKN1A transcription established a repressive transcriptional partnership and revealed HECW2-mediated ubiquitin-proteasome degradation as a mechanism controlling MORC4 protein turnover.","evidence":"Co-immunoprecipitation, luciferase reporter assay, proteasome inhibitor and ubiquitination assays in colorectal cancer cells","pmids":["36932196"],"confidence":"Medium","gaps":["HECW2-mediated degradation demonstrated by a single lab without independent confirmation","Ubiquitination sites on MORC4 not mapped","Whether PCGF1 interaction is direct or within a larger Polycomb complex is unresolved"]},{"year":2025,"claim":"A hepatocyte knockdown/overexpression study linked MORC4 to regulation of hepatic lipid metabolism, revealing effects on cholesterol synthesis (HMGCR) and lipid uptake/hydrolysis genes, broadening MORC4's functional scope beyond cancer biology.","evidence":"siRNA knockdown and overexpression in hepatocytes with TC/TG assays and gene expression profiling","pmids":["40606021"],"confidence":"Low","gaps":["No direct molecular mechanism connecting MORC4 chromatin activity to lipid gene regulation","Single-lab study without in vivo genetic confirmation in conditional knockout models","Whether MORC4 acts at lipid-gene promoters directly or via intermediary factors is unknown"]},{"year":null,"claim":"Genome-wide identification of MORC4's chromatin targets, the composition of MORC4 nuclear bodies, and the structural basis for its transcriptional partner selectivity (STAT3 vs. PCGF1) remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No genome-wide ChIP-seq or CUT&RUN map of MORC4 occupancy exists","Proteomic characterization of MORC4 nuclear bodies is lacking","Structural basis for selective engagement with activating (STAT3) versus repressive (PCGF1) partners unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,1]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,3]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,8]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1]}],"complexes":[],"partners":["STAT3","PCGF1","HECW2"],"other_free_text":[]},"mechanistic_narrative":"MORC4 is a nuclear ATPase that regulates chromatin accessibility, nuclear body formation, and transcriptional programs through cooperative DNA binding and nucleosome remodeling. Its ATPase activity is stimulated by DNA engagement through both its ATPase and CW zinc-finger domains; structurally, the CW domain positions DNA-binding and histone-contact surfaces on opposite faces, enabling MORC4 to bind nucleosome core particles, enhance DNA wrapping around histones, and occlude transcription factor access [PMID:33122719]. In cells, MORC4 drives nuclear body formation and S-phase progression in a CW- and ATPase-dependent manner, and it modulates transcription by cooperating with STAT3 to activate the MID2 promoter and with PCGF1 to repress CDKN1A [PMID:33122719, PMID:32764967, PMID:36932196]. MORC4 protein levels are regulated post-translationally by HECW2-mediated ubiquitin-proteasome degradation and post-transcriptionally by miR-193b-3p and miR-338-3p [PMID:36932196, PMID:30320920, PMID:31908485]."},"prefetch_data":{"uniprot":{"accession":"Q8TE76","full_name":"MORC family CW-type zinc finger protein 4","aliases":["Zinc finger CW-type coiled-coil domain protein 2","Zinc finger CW-type domain protein 4"],"length_aa":937,"mass_kda":106.3,"function":"Histone methylation reader which binds to non-methylated (H3K4me0), monomethylated (H3K4me1), dimethylated (H3K4me2) and trimethylated (H3K4me3) 'Lys-4' on histone H3 (PubMed:26933034). The order of binding preference is H3K4me3 > H3K4me2 > H3K4me1 > H3K4me0 (PubMed:26933034)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8TE76/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MORC4","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MORC4","total_profiled":1310},"omim":[{"mim_id":"300970","title":"MORC FAMILY CW-TYPE ZINC FINGER PROTEIN 4; MORC4","url":"https://www.omim.org/entry/300970"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"placenta","ntpm":74.7}],"url":"https://www.proteinatlas.org/search/MORC4"},"hgnc":{"alias_symbol":["ZCW4","FLJ11565"],"prev_symbol":["ZCWCC2"]},"alphafold":{"accession":"Q8TE76","domains":[{"cath_id":"3.30.565","chopping":"38-248_262-275","consensus_level":"high","plddt":91.8437,"start":38,"end":275},{"cath_id":"3.30.230.10","chopping":"301-407","consensus_level":"medium","plddt":91.5331,"start":301,"end":407},{"cath_id":"3.30.40.100","chopping":"425-470","consensus_level":"medium","plddt":89.8415,"start":425,"end":470},{"cath_id":"1.10.287","chopping":"771-878","consensus_level":"high","plddt":75.7275,"start":771,"end":878},{"cath_id":"1.10.8","chopping":"883-934","consensus_level":"high","plddt":82.6285,"start":883,"end":934}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TE76","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TE76-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TE76-F1-predicted_aligned_error_v6.png","plddt_mean":67.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MORC4","jax_strain_url":"https://www.jax.org/strain/search?query=MORC4"},"sequence":{"accession":"Q8TE76","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TE76.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TE76/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TE76"}},"corpus_meta":[{"pmid":"25253127","id":"PMC_25253127","title":"Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study.","date":"2014","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/25253127","citation_count":85,"is_preprint":false},{"pmid":"31908485","id":"PMC_31908485","title":"Baicalin Inhibits Cell Viability, Migration and Invasion in Breast Cancer by Regulating miR-338-3p and MORC4.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31908485","citation_count":41,"is_preprint":false},{"pmid":"30320920","id":"PMC_30320920","title":"MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.","date":"2018","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30320920","citation_count":34,"is_preprint":false},{"pmid":"17608765","id":"PMC_17608765","title":"MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.","date":"2007","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/17608765","citation_count":33,"is_preprint":false},{"pmid":"26820620","id":"PMC_26820620","title":"Common Variants in CLDN2 and MORC4 Genes Confer Disease Susceptibility in Patients with Chronic Pancreatitis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26820620","citation_count":27,"is_preprint":false},{"pmid":"32764967","id":"PMC_32764967","title":"MORC4 Promotes Chemoresistance of Luminal A/B Breast Cancer via STAT3-Mediated MID2 Upregulation.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/32764967","citation_count":21,"is_preprint":false},{"pmid":"33122719","id":"PMC_33122719","title":"Molecular mechanism of the MORC4 ATPase activation.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33122719","citation_count":20,"is_preprint":false},{"pmid":"26784911","id":"PMC_26784911","title":"Association Analysis of PRSS1-PRSS2 and CLDN2-MORC4 Variants in Nonalcoholic Chronic Pancreatitis Using Tropical Calcific Pancreatitis as Model.","date":"2016","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/26784911","citation_count":13,"is_preprint":false},{"pmid":"26827181","id":"PMC_26827181","title":"Single Nucleotide Polymorphisms in MORC4, CD14, and TLR4 Are Related to Outcome of Allogeneic Stem Cell Transplantation.","date":"2016","source":"Annals of transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/26827181","citation_count":9,"is_preprint":false},{"pmid":"36932196","id":"PMC_36932196","title":"MORC4 plays a tumor-promoting role in colorectal cancer via regulating PCGF1/CDKN1A axis in vitro and in vivo.","date":"2023","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/36932196","citation_count":7,"is_preprint":false},{"pmid":"39256868","id":"PMC_39256868","title":"Exosome-mediated transfer of lncRNA RP3-340B19.3 promotes the progression of breast cancer by sponging miR-4510/MORC4 axis.","date":"2024","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/39256868","citation_count":4,"is_preprint":false},{"pmid":"30865939","id":"PMC_30865939","title":"Spatial and temporal resolution of mORC4 fluorescent variants reveals structural requirements for achieving higher order self-association and pronuclei entry.","date":"2019","source":"Methods and applications in fluorescence","url":"https://pubmed.ncbi.nlm.nih.gov/30865939","citation_count":3,"is_preprint":false},{"pmid":"40606021","id":"PMC_40606021","title":"Morc4 is a novel functional gene associated with lipid metabolism in BXD recombinant inbred population.","date":"2025","source":"Frontiers in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40606021","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":9038,"output_tokens":2268,"usd":0.030567},"stage2":{"model":"claude-opus-4-6","input_tokens":5582,"output_tokens":2413,"usd":0.132353},"total_usd":0.16292,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2020,\n      \"finding\": \"MORC4 has intrinsic ATPase activity that is dependent on DNA-binding functions of both its ATPase domain and CW domain; the crystal structure of the ATPase-CW cassette shows that the DNA-binding site and the histone/ATPase binding site of CW are on opposite sides of the domain; MORC4 and CW domains cooperate to bind the nucleosome core particle (NCP), enhancing DNA wrapping around the histone core and impeding binding of DNA-associated proteins such as transcription factors to the NCP.\",\n      \"method\": \"Enzymatic ATPase assays, binding assays, crystal structure determination, mutagenesis studies, nucleosome core particle binding assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus enzymatic assays plus mutagenesis in a single rigorous study\",\n      \"pmids\": [\"33122719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In cells, MORC4 mediates formation of nuclear bodies in the nucleus and has a role in progression of S-phase of the cell cycle; both functions require the CW domain and catalytic ATPase activity of MORC4.\",\n      \"method\": \"Cell-based assays with CW domain and catalytic mutants, nuclear body imaging, cell cycle analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with domain-specific mutants and defined cellular phenotypes in a rigorous study\",\n      \"pmids\": [\"33122719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MORC4 physically interacts with STAT3 (confirmed by Co-IP), and MORC4 promotes STAT3-mediated transcriptional activation of the MID2 promoter (confirmed by ChIP-qPCR and dual-luciferase assay), leading to MID2 upregulation and chemoresistance in luminal A/B breast cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, ChIP-qPCR, dual-luciferase reporter assay, siRNA knockdown/overexpression\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus ChIP and reporter assay, single lab\",\n      \"pmids\": [\"32764967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MORC4 physically interacts with PCGF1 (a transcriptional repressor of CDKN1A/p21) as shown by co-immunoprecipitation; MORC4 augments PCGF1-mediated repression of CDKN1A transcription, thereby promoting colorectal cancer cell proliferation and metastasis.\",\n      \"method\": \"Co-immunoprecipitation, luciferase reporter assay, siRNA knockdown, overexpression\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with reporter assay and functional rescue, single lab\",\n      \"pmids\": [\"36932196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MORC4 protein is degraded through the ubiquitin-proteasome system and acts as a substrate of the E3 ubiquitin ligase HECW2.\",\n      \"method\": \"Co-immunoprecipitation, proteasome inhibitor assays, ubiquitination assays\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, single method, limited mechanistic detail in abstract\",\n      \"pmids\": [\"36932196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"miR-193b-3p directly targets the 3' UTR of MORC4 mRNA and negatively regulates MORC4 protein levels in breast cancer cells; MORC4 silencing promotes apoptosis and suppresses breast cancer cell growth.\",\n      \"method\": \"Dual-luciferase reporter assay, Western blot, siRNA knockdown, miRNA overexpression\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — luciferase reporter plus functional rescue, replicated in cell lines and tissues\",\n      \"pmids\": [\"30320920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"miR-338-3p directly targets MORC4 (confirmed by luciferase reporter assay and RNA immunoprecipitation); baicalin upregulates miR-338-3p, leading to decreased MORC4 expression and suppressed breast cancer cell viability, migration, and invasion.\",\n      \"method\": \"Luciferase reporter assay, RNA immunoprecipitation, Western blot, MTT assay, transwell migration/invasion, flow cytometry\",\n      \"journal\": \"OncoTargets and therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — luciferase and RIP confirm direct miR-MORC4 interaction, functional rescue shown\",\n      \"pmids\": [\"31908485\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"lncRNA RP3-340B19.3 acts as a competing endogenous RNA (ceRNA) by sponging miR-4510, thereby upregulating MORC4 expression and activating NF-κB and Wnt-β-catenin signaling pathways to promote breast cancer proliferation and metastasis.\",\n      \"method\": \"Dual luciferase reporter assay, Western blotting, bioinformatics, transwell and clone formation assays\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, indirect ceRNA mechanism, limited mechanistic validation of MORC4's downstream role\",\n      \"pmids\": [\"39256868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MORC4 protein contains a HATPase-c domain, CW zinc finger motif, nuclear localisation signals, a nuclear matrix-binding domain, and a coiled-coil region, establishing its domain architecture and nuclear localization.\",\n      \"method\": \"Sequence analysis, antibody detection, mRNA expression profiling in cell lines\",\n      \"journal\": \"British journal of haematology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 — domain identification by sequence analysis; no direct functional assay of domains\",\n      \"pmids\": [\"17608765\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MORC4 knockdown in hepatocytes elevates total cholesterol and triglyceride levels and increases lipid accumulation, while MORC4 overexpression reverses these effects; MORC4 knockdown increases expression of cholesterol synthesis gene HMGCR and alters expression of fatty acid/cholesterol uptake genes (PCSK9, PLTP, CD36) and triglyceride hydrolysis genes (APOC2, APOA4, LIPG, LIPA), indicating a role for MORC4 in hepatic lipid metabolism.\",\n      \"method\": \"siRNA knockdown, overexpression, TC/TG assays, lipid accumulation assays, gene expression analysis in hepatocytes; in vivo Morc4 knockout mouse data from IMPC database\",\n      \"journal\": \"Frontiers in cardiovascular medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, cellular phenotype without direct pathway placement or molecular mechanism\",\n      \"pmids\": [\"40606021\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MORC4 is a nuclear ATPase whose catalytic activity is activated by cooperative DNA binding through both its ATPase and CW domains; it binds nucleosome core particles to enhance DNA wrapping and occlude transcription factor access, interacts with STAT3 to drive MID2 transcription and chemoresistance, interacts with PCGF1 to repress CDKN1A, is subject to HECW2-mediated ubiquitin-proteasome degradation, is negatively regulated post-transcriptionally by miR-193b-3p and miR-338-3p, mediates nuclear body formation and S-phase progression in a CW- and ATPase-dependent manner, and regulates hepatic lipid metabolism.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MORC4 is a nuclear ATPase that regulates chromatin accessibility, nuclear body formation, and transcriptional programs through cooperative DNA binding and nucleosome remodeling. Its ATPase activity is stimulated by DNA engagement through both its ATPase and CW zinc-finger domains; structurally, the CW domain positions DNA-binding and histone-contact surfaces on opposite faces, enabling MORC4 to bind nucleosome core particles, enhance DNA wrapping around histones, and occlude transcription factor access [PMID:33122719]. In cells, MORC4 drives nuclear body formation and S-phase progression in a CW- and ATPase-dependent manner, and it modulates transcription by cooperating with STAT3 to activate the MID2 promoter and with PCGF1 to repress CDKN1A [PMID:33122719, PMID:32764967, PMID:36932196]. MORC4 protein levels are regulated post-translationally by HECW2-mediated ubiquitin-proteasome degradation and post-transcriptionally by miR-193b-3p and miR-338-3p [PMID:36932196, PMID:30320920, PMID:31908485].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Initial characterization established the domain architecture of MORC4 — including its ATPase, CW zinc-finger, nuclear localization signals, and coiled-coil regions — providing the first framework for predicting its nuclear function.\",\n      \"evidence\": \"Sequence analysis and antibody detection in cell lines\",\n      \"pmids\": [\"17608765\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No functional assays of any domain were performed\",\n        \"Nuclear localization inferred from sequence motifs, not imaging\",\n        \"Enzymatic activity of the predicted ATPase domain untested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The identification of miR-193b-3p as a direct negative regulator of MORC4 mRNA established that MORC4 expression is subject to microRNA-mediated post-transcriptional control and linked MORC4 levels to breast cancer cell survival.\",\n      \"evidence\": \"Dual-luciferase reporter assay confirming 3′ UTR targeting, Western blot, and functional knockdown in breast cancer cell lines\",\n      \"pmids\": [\"30320920\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Downstream effectors of MORC4 in the pro-survival phenotype were not identified\",\n        \"In vivo validation of miR-193b-3p–MORC4 axis absent\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A second microRNA, miR-338-3p, was shown to directly target MORC4, reinforcing the post-transcriptional regulatory layer and connecting MORC4 downregulation to suppressed breast cancer migration and invasion.\",\n      \"evidence\": \"Luciferase reporter assay and RNA immunoprecipitation confirming direct binding, functional rescue in breast cancer cells\",\n      \"pmids\": [\"31908485\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Relative contributions of miR-193b-3p versus miR-338-3p to endogenous MORC4 regulation unclear\",\n        \"The pharmacological agent (baicalin) used to upregulate the miRNA adds confounding variables\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Structural and biochemical work resolved how MORC4 functions as a DNA-stimulated ATPase: the crystal structure of the ATPase-CW cassette revealed cooperative DNA binding by both domains, and nucleosome core particle assays showed MORC4 enhances histone–DNA wrapping while occluding transcription factor binding, establishing its chromatin-remodeling mechanism.\",\n      \"evidence\": \"Crystal structure determination, enzymatic ATPase assays, mutagenesis, and nucleosome core particle binding assays\",\n      \"pmids\": [\"33122719\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Genomic targets of MORC4's nucleosome-remodeling activity in vivo are unknown\",\n        \"Whether MORC4 acts catalytically (turnover on multiple nucleosomes) or stoichiometrically is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Cell-based studies demonstrated that MORC4 drives nuclear body formation and S-phase progression through its CW domain and ATPase catalytic activity, linking the in vitro biochemistry to defined cellular phenotypes.\",\n      \"evidence\": \"CW and catalytic-dead mutant analysis, nuclear body imaging, cell cycle analysis\",\n      \"pmids\": [\"33122719\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Composition of MORC4-containing nuclear bodies is uncharacterized\",\n        \"Mechanism connecting nucleosome remodeling to S-phase progression is not delineated\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"MORC4 was shown to physically interact with STAT3 and co-occupy the MID2 promoter, establishing a transcriptional co-activator function that promotes chemoresistance in breast cancer cells.\",\n      \"evidence\": \"Co-immunoprecipitation, ChIP-qPCR, dual-luciferase reporter assay, and siRNA knockdown in luminal A/B breast cancer cells\",\n      \"pmids\": [\"32764967\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether MORC4's ATPase or nucleosome-remodeling activity is required for STAT3 co-activation is untested\",\n        \"Generality of MORC4–STAT3 cooperation beyond the MID2 locus unknown\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"The discovery that MORC4 interacts with PCGF1 to repress CDKN1A transcription established a repressive transcriptional partnership and revealed HECW2-mediated ubiquitin-proteasome degradation as a mechanism controlling MORC4 protein turnover.\",\n      \"evidence\": \"Co-immunoprecipitation, luciferase reporter assay, proteasome inhibitor and ubiquitination assays in colorectal cancer cells\",\n      \"pmids\": [\"36932196\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"HECW2-mediated degradation demonstrated by a single lab without independent confirmation\",\n        \"Ubiquitination sites on MORC4 not mapped\",\n        \"Whether PCGF1 interaction is direct or within a larger Polycomb complex is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"A hepatocyte knockdown/overexpression study linked MORC4 to regulation of hepatic lipid metabolism, revealing effects on cholesterol synthesis (HMGCR) and lipid uptake/hydrolysis genes, broadening MORC4's functional scope beyond cancer biology.\",\n      \"evidence\": \"siRNA knockdown and overexpression in hepatocytes with TC/TG assays and gene expression profiling\",\n      \"pmids\": [\"40606021\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No direct molecular mechanism connecting MORC4 chromatin activity to lipid gene regulation\",\n        \"Single-lab study without in vivo genetic confirmation in conditional knockout models\",\n        \"Whether MORC4 acts at lipid-gene promoters directly or via intermediary factors is unknown\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Genome-wide identification of MORC4's chromatin targets, the composition of MORC4 nuclear bodies, and the structural basis for its transcriptional partner selectivity (STAT3 vs. PCGF1) remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No genome-wide ChIP-seq or CUT&RUN map of MORC4 occupancy exists\",\n        \"Proteomic characterization of MORC4 nuclear bodies is lacking\",\n        \"Structural basis for selective engagement with activating (STAT3) versus repressive (PCGF1) partners unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"STAT3\",\n      \"PCGF1\",\n      \"HECW2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}